Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TS03 Inc Trust Units TSTIF

Healthcare Medical Instruments & Supplies


GREY:TSTIF - Post by User

TS03 Inc Trust Units > Echelon Target Maintained 1.25 Buy
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(3)
•••
Comment by MarylnMansonon May 07, 2019 9:40pm
154 Views
Post# 29722633

RE:RE:Echelon Target Maintained 1.25 Buy

RE:RE:Echelon Target Maintained 1.25 Buy
Cash and Echo, you guys really have lost your minds.  Why don't you go back and look at Doug Loe's research, he has always had the highest target and the most aggressive estimates on the street well beyond any other analyst or reality.  By now according to his old estimates i think 1000 units were supposed to have been sold.  Loe is the only analyst more bullish than the crazy ceo.....and both have been equally wrong.  So Loe's 1.25 target isn't super inspiring considering it is down from $6.  His analysis should be thrown out like yesterdays news.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities